|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Rockefeller University |
|---|---|
| Information provided by: | Rockefeller University |
| ClinicalTrials.gov Identifier: | NCT00481637 |
Purpose
The purpose of this study is to study whether immune cells capable of killing tumors that express proteins associated with paraneoplastic neurologic syndrome (PNS) can be found in small cell lung cancer and ovarian cancer patients. The presence of these cells may play a role in tumor immunity in these patients. The protocol involves neurological examinations and collection of blood.
| Condition |
|---|
|
Healthy |
| Study Type: | Observational |
| Study Design: | Natural History, Cross-Sectional, Defined Population, Prospective Study |
| Official Title: | Tumor Immunity in Neurologically Normal Patients |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Mayu Frank, MS ANP | 212-327-7443 | frankm@rockefeller.edu |
| United States, New York | |
| Rockefeller University Hospital | Recruiting |
| New York, New York, United States, 10021 | |
| Contact: Mayu Frank, MS ANP 212-327-7443 | |
| Principal Investigator: Robert Darnell, MD, PHD | |
| Principal Investigator: | Robert Darnell, MD, PHD | Rockefeller University |
More Information
| Study ID Numbers: | RUH IRB #RDA-269 |
| Study First Received: | June 1, 2007 |
| Last Updated: | June 13, 2007 |
| ClinicalTrials.gov Identifier: | NCT00481637 |
| Health Authority: | United States: Institutional Review Board |
|
To evaluate immune responses in neurologically normal cancer patients |
|
Healthy |
